1. Home
  2. Pharma & Healthcare
  3. Global OTC Artificial Tears Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Global OTC Artificial Tears Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Publication Month: Sep 2021 | No. of Pages: 130 Published By: GRD Survey
Single User License: US $ 3980
Corporate User License: US $ 7960

Executive Summary

According to GRD Survey data, the global OTC Artificial Tears market was valued at million US$ in 2020 and is expected to million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.

This report studies the OTC Artificial Tears market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of OTC Artificial Tears in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Preservative Based
Non-preservative Based

Market Snapshot, By Application
Hospital Pharmacies
Drug Stores
Online

Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia

Main Market Players Analyzed in this report, including:
Ursapharm Arzneimittel GmbH
Sun Pharmaceutical Industries Limited
Similasan Corporation
Santen Pharmaceutical Co. Ltd
OcuSoft
Johnson and Johnson
Bausch and Lamb
Alcon
Akorn, Inc.
AbbVie, Inc.

The study objectives of this report are:
To study and analyze the global OTC Artificial Tears market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of OTC Artificial Tears market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global OTC Artificial Tears manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the OTC Artificial Tears market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of OTC Artificial Tears submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of OTC Artificial Tears are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 OTC Artificial Tears Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global OTC Artificial Tears Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter's Five Forces Analysis
2.3 Comparison of Alternatives and OTC Artificial Tears

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 OTC Artificial Tears Sales Channel and Distributors Analysis
3.3.1 OTC Artificial Tears Sales Channel
3.3.2 OTC Artificial Tears Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Application One
3.4.2 Major Buyers in Application Two
3.4.1 Major Buyers in Application Three
3.5 OTC Artificial Tears Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 OTC Artificial Tears Type Introduction
4.1.1 Preservative Based
4.1.2 Non-preservative Based
4.2 Global OTC Artificial Tears Sales by Type 2016-2021
4.3 Global OTC Artificial Tears Revenue by Type 2016-2021
4.4 Global OTC Artificial Tears Price by Type 2016-2021

5 Market Segment: by Application
5.1 OTC Artificial Tears Type Introduction
5.1.1 Hospital Pharmacies
5.1.2 Drug Stores
5.1.3 Online
5.2 Global OTC Artificial Tears Sales by Application 2016-2021
5.3 Global OTC Artificial Tears Revenue by Application 2016-2021
5.4 Global OTC Artificial Tears Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global OTC Artificial Tears Market by Region
6.1.1 Global OTC Artificial Tears Sales by Regions
6.1.2 Global OTC Artificial Tears Revenue by Regions
6.2 North America OTC Artificial Tears Market 2016-2021
6.3 Europe OTC Artificial Tears Market 2016-2021
6.4 Asia Pacific OTC Artificial Tears Market 2016-2021
6.5 South America OTC Artificial Tears Market 2016-2021
6.6 Middle East and Africa OTC Artificial Tears Market 2016-2021

7 North America
7.1 North America OTC Artificial Tears Market by Country 2016-2021
7.1.1 North America OTC Artificial Tears Sales by Country
7.1.2 North America OTC Artificial Tears Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe OTC Artificial Tears Market by Country 2016-2021
8.1.1 Europe OTC Artificial Tears Sales by Country
8.1.2 Europe OTC Artificial Tears Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific OTC Artificial Tears Market by Country 2016-2021
9.1.1 Asia Pacific OTC Artificial Tears Sales by Country
9.1.2 Asia Pacific OTC Artificial Tears Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America OTC Artificial Tears Market by Country 2016-2021
10.1.1 South America OTC Artificial Tears Sales by Country
10.1.2 South America OTC Artificial Tears Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa OTC Artificial Tears Market by Country 2016-2021
11.1.1 Middle East and Africa OTC Artificial Tears Sales by Country
11.1.2 Middle East and Africa OTC Artificial Tears Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Ursapharm Arzneimittel GmbH
12.1.1 Ursapharm Arzneimittel GmbH Company Information
12.1.2 Ursapharm Arzneimittel GmbH OTC Artificial Tears Product Portfolio, Specification and Application
12.1.3 Ursapharm Arzneimittel GmbH OTC Artificial Tears Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Ursapharm Arzneimittel GmbH Key Development
12.2 Sun Pharmaceutical Industries Limited
12.2.1 Sun Pharmaceutical Industries Limited Company Information
12.2.2 Sun Pharmaceutical Industries Limited OTC Artificial Tears Product Portfolio, Specification and Application
12.2.3 Sun Pharmaceutical Industries Limited OTC Artificial Tears Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Sun Pharmaceutical Industries Limited Key Development
12.3 Similasan Corporation
12.3.1 Similasan Corporation Company Information
12.3.2 Similasan Corporation OTC Artificial Tears Product Portfolio, Specification and Application
12.3.3 Similasan Corporation OTC Artificial Tears Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Similasan Corporation Key Development
12.4 Santen Pharmaceutical Co. Ltd
12.4.1 Santen Pharmaceutical Co. Ltd Company Information
12.4.2 Santen Pharmaceutical Co. Ltd OTC Artificial Tears Product Portfolio, Specification and Application
12.4.3 Santen Pharmaceutical Co. Ltd OTC Artificial Tears Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Santen Pharmaceutical Co. Ltd Key Development
12.5 OcuSoft
12.5.1 OcuSoft Company Information
12.5.2 OcuSoft OTC Artificial Tears Product Portfolio, Specification and Application
12.5.3 OcuSoft OTC Artificial Tears Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 OcuSoft Key Development
12.6 Johnson and Johnson
12.6.1 Johnson and Johnson Company Information
12.6.2 Johnson and Johnson OTC Artificial Tears Product Portfolio, Specification and Application
12.6.3 Johnson and Johnson OTC Artificial Tears Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Johnson and Johnson Key Development
12.7 Bausch and Lamb
12.7.1 Bausch and Lamb Company Information
12.7.2 Bausch and Lamb OTC Artificial Tears Product Portfolio, Specification and Application
12.7.3 Bausch and Lamb OTC Artificial Tears Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Johnson and Johnson Key Development
12.9 Akorn, Inc.
12.9.1 Akorn, Inc. Company Information
12.9.2 Akorn, Inc. OTC Artificial Tears Product Portfolio, Specification and Application
12.9.3 Akorn, Inc. OTC Artificial Tears Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Akorn, Inc. Key Development
12.8 Alcon
12.8.1 Alcon Company Information
12.8.2 Alcon OTC Artificial Tears Product Portfolio, Specification and Application
12.8.3 Alcon OTC Artificial Tears Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Alcon Key Development

13 Global OTC Artificial Tears Market Forecast by Region by Type and by Application
13.1 Global OTC Artificial Tears Sales, Revenue Forecast 2022-2027
13.2 Global OTC Artificial Tears Forecast by Regions
13.2.1 Global OTC Artificial Tears Sales Forecast by Region 2022-2027
13.2.2 Global OTC Artificial Tears Revenue Forecast by Region 2022-2027
13.3 Global OTC Artificial Tears Forecast by Type
13.3.1 Global OTC Artificial Tears Sales Forecast by Type 2022-2027
13.3.2 Global OTC Artificial Tears Revenue Forecast by Type 2022-2027
13.3.3 Global OTC Artificial Tears Price Forecast by Type 2022-2027
13.4 Global OTC Artificial Tears Forecast by Application
13.4.1 Global OTC Artificial Tears Sales Forecast by Application 2022-2027
13.4.2 Global OTC Artificial Tears Revenue Forecast by Application 2022-2027
13.4.3 Global OTC Artificial Tears Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer


List of Tables

Table 1: Global OTC Artificial Tears Production Specifications
Table 2: Drivers in OTC Artificial Tears Market
Table 3: Restraints OTC Artificial Tears Market
Table 4: Opportunity in OTC Artificial Tears Market
Table 5: Comparion of Alternative and OTC Artificial Tears
Table 6: OTC Artificial Tears Raw Materials Key Suppliers List
Table 7: OTC Artificial Tears Distributors List
Table 8: OTC Artificial Tears Major Buyers in Application One
Table 9: OTC Artificial Tears Major Buyers in Application Two
Table 10: OTC Artificial Tears Major Buyers in Application Three
Table 11: Global OTC Artificial Tears Sales (K Units) by Type 2016-2021
Table 12: Global OTC Artificial Tears Sales Market Share by Type 2016-2021
Table 13: Global OTC Artificial Tears Revenue (Million USD) by Type 2016-2021
Table 14: Global OTC Artificial Tears Revenue Market Share by Type 2016-2021
Table 15: Global OTC Artificial Tears Price by Type 2016-2021
Table 16: Global OTC Artificial Tears Sales (K Units) by Application 2016-2021
Table 17: Global OTC Artificial Tears Sales Market Share by Application 2016-2021
Table 18: Global OTC Artificial Tears Revenue (Million USD) by Application 2016-2021
Table 19: Global OTC Artificial Tears Revenue Market Share by Application 2016-2021
Table 20: Global OTC Artificial Tears Price by Application 2016-2021
Table 21: Global OTC Artificial Tears Sales (K Units) by Region 2016-2021
Table 22: Global OTC Artificial Tears Sales Market Share by Region 2016-2021
Table 23: Global OTC Artificial Tears Revenue (Million USD) by Region 2016-2021
Table 24: Global OTC Artificial Tears Revenue Market Share by Region 2016-2021
Table 25: North America OTC Artificial Tears Sales (K Units) by Country 2016-2021
Table 26: North America OTC Artificial Tears Sales Market Share by Country 2016-2021
Table 27: North America OTC Artificial Tears Revenue (Million USD) by Country 2016-2021
Table 28: North America OTC Artificial Tears Revenue Market Share by Country 2016-2021)
Table 29: Europe OTC Artificial Tears Sales (K Units) by Country 2016-2021
Table 30: Europe OTC Artificial Tears Sales Market Share by Country 2016-2021
Table 31: Europe OTC Artificial Tears Revenue (Million USD) by Country 2016-2021
Table 32: Europe OTC Artificial Tears Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific OTC Artificial Tears Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific OTC Artificial Tears Sales Market Share by Country 2016-2021
Table 35: Asia Pacific OTC Artificial Tears Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific OTC Artificial Tears Revenue Market Share by Country 2016-2021)
Table 37: South America OTC Artificial Tears Sales (K Units) by Country 2016-2021
Table 38: South America OTC Artificial Tears Sales Market Share by Country 2016-2021
Table 39: South America OTC Artificial Tears Revenue (Million USD) by Country 2016-2021
Table 40: South America OTC Artificial Tears Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa OTC Artificial Tears Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa OTC Artificial Tears Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa OTC Artificial Tears Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa OTC Artificial Tears Revenue Market Share by Country 2016-2021)
Table 45 Ursapharm Arzneimittel GmbH Company Information
Table 46 Ursapharm Arzneimittel GmbH OTC Artificial Tears Product Portfolio, Specification and Application
Table 47 Ursapharm Arzneimittel GmbH OTC Artificial Tears Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Sun Pharmaceutical Industries Limited Company Information
Table 49 Sun Pharmaceutical Industries Limited OTC Artificial Tears Product Portfolio, Specification and Application
Table 50 Sun Pharmaceutical Industries Limited OTC Artificial Tears Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Similasan Corporation Company Information
Table 52 Similasan Corporation OTC Artificial Tears Product Portfolio, Specification and Application
Table 53 Similasan Corporation OTC Artificial Tears Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 Santen Pharmaceutical Co. Ltd Company Information
Table 55 Santen Pharmaceutical Co. Ltd OTC Artificial Tears Product Portfolio, Specification and Application
Table 56 Santen Pharmaceutical Co. Ltd OTC Artificial Tears Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 OcuSoft Company Information
Table 58 OcuSoft OTC Artificial Tears Product Portfolio, Specification and Application
Table 59 OcuSoft OTC Artificial Tears Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 Johnson and Johnson Company Information
Table 61 Johnson and Johnson OTC Artificial Tears Product Portfolio, Specification and Application
Table 62 Johnson and Johnson OTC Artificial Tears Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 Bausch and Lamb Company Information
Table 64 Bausch and Lamb OTC Artificial Tears Product Portfolio, Specification and Application
Table 65 Bausch and Lamb OTC Artificial Tears Sales, Price, Revenue and Gross Margin (2019-2021)
Table 66 Alcon Company Information
Table 67 Alcon OTC Artificial Tears Product Portfolio, Specification and Application
Table 68 Alcon OTC Artificial Tears Sales, Price, Revenue and Gross Margin (2019-2021)
Table 69 Akorn, Inc. Company Information
Table 70 Akorn, Inc. OTC Artificial Tears Product Portfolio, Specification and Application
Table 71 Akorn, Inc. OTC Artificial Tears Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global OTC Artificial Tears Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global OTC Artificial Tears Sales Market Share Forecast by Region (2012-2027)
Table 74: Global OTC Artificial Tears Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global OTC Artificial Tears Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global OTC Artificial Tears Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global OTC Artificial Tears Sales Market Share Forecast by Type (2012-2027)
Table 78: Global OTC Artificial Tears Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global OTC Artificial Tears Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global OTC Artificial Tears Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global OTC Artificial Tears Sales Market Share Forecast by Application (2012-2027)
Table 82: Global OTC Artificial Tears Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global OTC Artificial Tears Revenue Market Share Forecast by Application (2022-2027)

Tables and Figures

List of Figures

Figure 1: OTC Artificial Tears Picture
Figure 2: Global OTC Artificial Tears Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: OTC Artificial Tears Supply Chain Analysis
Figure 5: OTC Artificial Tears Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Preservative Based
Figure 7: Product Picture of Non-preservative Based
Figure 8: Global OTC Artificial Tears Sales Market Share by Type, 2020
Figure 9: Global OTC Artificial Tears Revenue Market Share by Type, 2020
Figure 10: OTC Artificial Tears in Hospital Pharmacies
Figure 11: Global OTC Artificial Tears Market: Hospital Pharmacies 2016-2021
Figure 12: OTC Artificial Tears in Drug Stores
Figure 13: Global OTC Artificial Tears Market: Drug Stores 2016-2021
Figure 14: Global OTC Artificial Tears Sales Market Share by Application, 2020
Figure 15: Global OTC Artificial Tears Revenue Market Share by Application, 2020
Figure 16: Global OTC Artificial Tears Sales Market Share by Region 2016-2021
Figure 17: Global OTC Artificial Tears Revenue Market Share by Region 2016-2021
Figure 18: North America OTC Artificial Tears Sales (K Units) Status 2016-2021
Figure 19: North America OTC Artificial Tears Revenue (Million USD) Status 2016-2021
Figure 20: Europe OTC Artificial Tears Sales (K Units) Status 2016-2021
Figure 21: Europe OTC Artificial Tears Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific OTC Artificial Tears Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific OTC Artificial Tears Revenue (Million USD) Status 2016-2021
Figure 24: South America OTC Artificial Tears Sales (K Units) Status 2016-2021
Figure 25: South America OTC Artificial Tears Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa OTC Artificial Tears Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa OTC Artificial Tears Revenue (Million USD) Status 2016-2021
Figure 28: North America OTC Artificial Tears Sales Market Share by Country, 2020
Figure 29: North America OTC Artificial Tears Revenue Market Share by Country, 2020
Figure 30: United States OTC Artificial Tears Sales (K Units) Status 2016-2021
Figure 31: United States OTC Artificial Tears Revenue (Million USD) Status 2016-2021
Figure 32: Canada OTC Artificial Tears Sales (K Units) Status 2016-2021
Figure 33: Canada OTC Artificial Tears Revenue (Million USD) Status 2016-2021
Figure 34: Mexico OTC Artificial Tears Sales (K Units) Status 2016-2021
Figure 35: Mexico OTC Artificial Tears Revenue (Million USD) Status 2016-2021
Figure 36: Europe OTC Artificial Tears Sales Market Share by Country, 2020
Figure 37: Europe OTC Artificial Tears Revenue Market Share by Country, 2020
Figure 38: Germany OTC Artificial Tears Sales (K Units) Status 2016-2021
Figure 39: Germany OTC Artificial Tears Revenue (Million USD) Status 2016-2021
Figure 40: France OTC Artificial Tears Sales (K Units) Status 2016-2021
Figure 41: France OTC Artificial Tears Revenue (Million USD) Status 2016-2021
Figure 42: UK OTC Artificial Tears Sales (K Units) Status 2016-2021
Figure 43: UK OTC Artificial Tears Revenue (Million USD) Status 2016-2021
Figure 44: Italy OTC Artificial Tears Sales (K Units) Status 2016-2021
Figure 45: Italy OTC Artificial Tears Revenue (Million USD) Status 2016-2021
Figure 46: Russia OTC Artificial Tears Sales (K Units) Status 2016-2021
Figure 46: Russia OTC Artificial Tears Revenue (Million USD) Status 2016-2021
Figure 47: Spain OTC Artificial Tears Sales (K Units) Status 2016-2021
Figure 48: Spain OTC Artificial Tears Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific OTC Artificial Tears Sales Market Share by Country, 2020
Figure 50: Asia Pacific OTC Artificial Tears Revenue Market Share by Country, 2020
Figure 51: China OTC Artificial Tears Sales (K Units) Status 2016-2021
Figure 52: China OTC Artificial Tears Revenue (Million USD) Status 2016-2021
Figure 53: Japan OTC Artificial Tears Sales (K Units) Status 2016-2021
Figure 54: Japan OTC Artificial Tears Revenue (Million USD) Status 2016-2021
Figure 55: Korea OTC Artificial Tears Sales (K Units) Status 2016-2021
Figure 56: Korea OTC Artificial Tears Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia OTC Artificial Tears Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia OTC Artificial Tears Revenue (Million USD) Status 2016-2021
Figure 59: India OTC Artificial Tears Sales (K Units) Status 2016-2021
Figure 60: India OTC Artificial Tears Revenue (Million USD) Status 2016-2021
Figure 61: Australia OTC Artificial Tears Sales (K Units) Status 2016-2021
Figure 62: Australia OTC Artificial Tears Revenue (Million USD) Status 2016-2021
Figure 63: South America OTC Artificial Tears Sales Market Share by Country, 2020
Figure 64: South America OTC Artificial Tears Revenue Market Share by Country, 2020
Figure 65: Brazil OTC Artificial Tears Sales (K Units) Status 2016-2021
Figure 66: Brazil OTC Artificial Tears Revenue (Million USD) Status 2016-2021
Figure 67: Argentina OTC Artificial Tears Sales (K Units) Status 2016-2021
Figure 68: Argentina OTC Artificial Tears Revenue (Million USD) Status 2016-2021
Figure 69: Colombia OTC Artificial Tears Sales (K Units) Status 2016-2021
Figure 70: Colombia OTC Artificial Tears Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa OTC Artificial Tears Sales Market Share by Country, 2020
Figure 72: Middle East and Africa OTC Artificial Tears Revenue Market Share by Country, 2020
Figure 73: Turkey OTC Artificial Tears Sales (K Units) Status 2016-2021
Figure 74: Turkey OTC Artificial Tears Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia OTC Artificial Tears Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia OTC Artificial Tears Revenue (Million USD) Status 2016-2021
Figure 77: South Africa OTC Artificial Tears Sales (K Units) Status 2016-2021
Figure 78: South Africa OTC Artificial Tears Revenue (Million USD) Status 2016-2021
Figure 79: Ursapharm Arzneimittel GmbH OTC Artificial Tears Revenue Market Share Globally (2019-2021)
Figure 80: Sun Pharmaceutical Industries Limited OTC Artificial Tears Revenue Market Share Globally (2019-2021)
Figure 81: Similasan Corporation OTC Artificial Tears Revenue Market Share Globally (2019-2021)
Figure 82: Santen Pharmaceutical Co. Ltd OTC Artificial Tears Revenue Market Share Globally (2019-2021)
Figure 83: OcuSoft OTC Artificial Tears Revenue Market Share Globally (2019-2021)
Figure 84: Johnson and Johnson OTC Artificial Tears Revenue Market Share Globally (2019-2021)
Figure 85: Bausch and Lamb OTC Artificial Tears Revenue Market Share Globally (2019-2021)
Figure 86: Alcon OTC Artificial Tears Revenue Market Share Globally (2019-2021)
Figure 87: Akorn, Inc. OTC Artificial Tears Revenue Market Share Globally (2019-2021)
Figure 88: AbbVie, Inc. OTC Artificial Tears Revenue Market Share Globally (2019-2021)
Figure 89: Global OTC Artificial Tears Sales (K Units) Forecast (2022-2027)
Figure 90: Global OTC Artificial Tears Sales (K Units) Forecast (2022-2027)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets